Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

NCT00676819 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin aspart
DRUG: human insulin

Sponsor

Novo Nordisk A/S